FDA Clearance Tracker · K192842
HemoTrol Duo Low, HemoTrol Duo Normal, HemoTrol Duo High
Last checked: Nov 20, 2026Latest source record: Nov 15, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Nov 15, 2019
Substantially Equivalent
Time to decision
43 days
Received Oct 3, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K192842
- Device name
- HemoTrol Duo Low, HemoTrol Duo Normal, HemoTrol Duo High
- Applicant
- Eurotrol B.V.
- Applicant location
- Ede, NL
- Received
- Oct 3, 2019
- Decided
- Nov 15, 2019
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Control, Hemoglobin (GGM)
- Device class
- Class II
- Regulation
- 21 CFR 864.8625
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GGM. The earliest in FDA's data is K790310, decided Mar 21, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K192842
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Eurotrol B.V.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K182744 · Decided Feb 1, 2019 · 126 days after receipt
Device type: Control, Hemoglobin (GGM) · Laboratory Medicine & Pathology
- CueSee Hypoxic510(k)
K152553 · Decided Apr 22, 2016 · 227 days after receipt
Device type: Controls For Blood-Gases, (Assayed And Unassayed) (JJS) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.